4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-005380
Options or other derivatives
- Chief Commercial Officer acquired 523,414 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Baldry Mark Chief Commercial Officer | 2024-02-13 | Grant or award · Stock Appreciation Right | +523,414 | 523,414 | D | ||
Loading xslF345X05/wk-form4_1708121338.xml…